Clioquinol, a Drug for Alzheimer's Disease Specifically Interfering with Brain Metal Metabolism: Structural Characterization of Its Zinc(II) and Copper(II) Complexes
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Clioquinol, a 8-hydroxyquinoline derivative, is producing very encouraging results in the treatment of Alzheimer's disease (AD). Its biological effects are most likely ascribed to complexation of specific metal ions, such as copper(II) and zinc(II), critically associated with protein aggregation and degeneration processes in the brain. We report here, for the first time, a structural characterization of the zinc(II) and copper(II) complexes of clioquinol. A ligand to metal stoichiometry of 2:1 is found in both cases, though in the presence of quite different coordination polyhedra. The present findings are discussed in the frame of modern approaches to AD treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Clioquinol (CQ) [1062,1674,1710,1711] (Fig 7) is one existing (anti-parasitic) drug that has been proposed for use as an iron chelator, as it contains the known iron-chelating 8-hydroxyquinoline moiety. It has indeed enjoyed some success in this role.”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [1711]
Citations
Cites
Neurodegenerative diseases and oxidative stress
Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683
Copper, iron and zinc in Alzheimer's disease senile plaques
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120
Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447
Atwood, C. S., Moir, R. D., Huang, X., Scarpa, R. C., Bacarra, N. M. E., Romano, D. M., Hartshorn, M. A., Tanzi, R. E., & Bush, A. I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.12817 · Cited by 1,009
Ritchie, C. W., Bush, A. I., Mackinnon, A., Macfarlane, S., Mastwyk, M., MacGregor, L., Kiers, L., Cherny, R., Li, Q.-X., Tammer, A., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1685 · Cited by 988
Treatment of Alzheimer’s Disease with Clioquinol
Regland, B., Lehmann, W., Abedini, I., Blennow, K., Jonsson, M., Karlsson, I., Sjögren, M., Wallin, A., Xilinas, M., & Gottfries, C.-G. (2001) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051288 · Cited by 220
Metal Chelation as a Potential Therapy for Alzheimer's Disease
CUAJUNGCO, M. P., FAGÉT, K. Y., HUANG, X., TANZI, R. E., & BUSH, A. I. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06938.x · Cited by 215
Current Status of Metals as Therapeutic Targets in Alzheimer's Disease
Finefrock, A. E., Bush, A. I., & Doraiswamy, P. M. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51368.x · Cited by 204
Survival Study of Parkinson Disease in Olmsted County, Minnesota
Elbaz, A., Bower, J. H., Peterson, B. J., Maraganore, D. M., McDonnell, S. K., Ahlskog, J. E., Schaid, D. J., & Rocca, W. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.1.91 · Cited by 179
The crystal structure of the α form of anhydrous copper 8-hydroxyquinolinate
Hoy, R. C., & Morriss, R. H. (1967) · Acta Crystallographica · doi:10.1107/s0365110x67001008 · Cited by 42
Research works printed but not linked: 5
- Bush A. I., 2003, Trends Neurosci., 4, 14
- Metal Ions P., 2003, World Scientific: Singapore
- Huang X., 1997, J. Biol. Chem., 272, 26470
- Gerolymatos, December 14, 1999.
- García-Granda S., 1987, J. Acta Crystallogr., 43, 39
Cited by
Bioinorganic Chemistry of Alzheimer’s Disease
Kepp, K. P. (2012) · Chemical Reviews · doi:10.1021/cr300009x · Cited by 672
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
Novel Metals and Metal Complexes as Platforms for Cancer Therapy
Frezza, M., Hindo, S., Chen, D., Davenport, A., Schmitt, S., Tomco, D., & Ping Dou, Q. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791209009 · Cited by 552
Metallostasis in Alzheimer's disease
Ayton, S., Lei, P., & Bush, A. I. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.10.558 · Cited by 352
Daniel, K. G., Chen, D., Orlu, S., Cui, Q. C., Miller, F. R., & Dou, Q. P. (2005) · Breast Cancer Research · doi:10.1186/bcr1322 · Cited by 326
Copper complexes as therapeutic agents
Duncan, C., & White, A. R. (2012) · Metallomics · doi:10.1039/c2mt00174h · Cited by 294
White, A. R., Du, T., Laughton, K. M., Volitakis, I., Sharples, R. A., Xilinas, M. E., Hoke, D. E., Holsinger, R. M. D., Evin, G., Cherny, R. A., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602487200 · Cited by 284
8-Hydroxyquinolines in medicinal chemistry: A structural perspective
Oliveri, V., & Vecchio, G. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.05.007 · Cited by 281
Biological metals and Alzheimer's disease: Implications for therapeutics and diagnostics
Duce, J. A., & Bush, A. I. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.003 · Cited by 283
Psomas, G., & Kessissoglou, D. P. (2013) · Dalton Transactions · doi:10.1039/c3dt50268f · Cited by 263
Zinc coordination complexes as anticancer agents
Pellei, M., Del Bello, F., Porchia, M., & Santini, C. (2021) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2021.214088 · Cited by 245
Tardito, S., Barilli, A., Bassanetti, I., Tegoni, M., Bussolati, O., Franchi-Gazzola, R., Mucchino, C., & Marchiò, L. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301053a · Cited by 226
Robert, A., Liu, Y., Nguyen, M., & Meunier, B. (2015) · Accounts of Chemical Research · doi:10.1021/acs.accounts.5b00119 · Cited by 212
Chen, D., Cui, Q. C., Yang, H., Barrea, R. A., Sarkar, F. H., Sheng, S., Yan, B., Reddy, G. P. V., & Dou, Q. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3546 · Cited by 212
Copper Coordination Compounds as Biologically Active Agents
Krasnovskaya, O., Naumov, A., Guk, D., Gorelkin, P., Erofeev, A., Beloglazkina, E., & Majouga, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113965 · Cited by 198
Metal ions, Alzheimer's disease and chelation therapy
Budimir, A. (2011) · Acta Pharmaceutica · doi:10.2478/v10007-011-0006-6 · Cited by 202
Kaur, K., Gupta, R., Saraf, S. A., & Saraf, S. K. (2014) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12067 · Cited by 197
Rajan, R., Ahmed, S., Sharma, N., Kumar, N., Debas, A., & Matsumura, K. (2021) · Materials Advances · doi:10.1039/d0ma00760a · Cited by 196
Copper-mediated Amyloid-β Toxicity Is Associated with an Intermolecular Histidine Bridge
Smith, D. P., Smith, D. G., Curtain, C. C., Boas, J. F., Pilbrow, J. R., Ciccotosto, G. D., Lau, T.-L., Tew, D. J., Perez, K., Wade, J. D., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600417200 · Cited by 187
Polyphenols as Potential Metal Chelation Compounds Against Alzheimer’s Disease
Lakey-Beitia, J., Burillo, A. M., La Penna, G., Hegde, M. L., & Rao, K. S. (2021) · Journal of Alzheimer's Disease · doi:10.3233/jad-200185 · Cited by 177
Zinc Complexes with Nitrogen Donor Ligands as Anticancer Agents
Porchia, M., Pellei, M., Del Bello, F., & Santini, C. (2020) · Molecules · doi:10.3390/molecules25245814 · Cited by 179
A Perspective – can copper complexes be developed as a novel class of therapeutics?
Wehbe, M., Leung, A. W. Y., Abrams, M. J., Orvig, C., & Bally, M. B. (2017) · Dalton Transactions · doi:10.1039/c7dt01955f · Cited by 173
Protein aggregation: From background to inhibition strategies
Alam, P., Siddiqi, K., Chturvedi, S. K., & Khan, R. H. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.05.048 · Cited by 166
Challenges Associated with Metal Chelation Therapy in Alzheimer's Disease
Hegde, M. L., Bharathi, P., Suram, A., Venugopal, C., Jagannathan, R., Poddar, P., Srinivas, P., Sambamurti, K., Rao, K. J., Scancar, J., et al. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1068 · Cited by 167
Self-citationInteraction of Zn(ii) with quinolone drugs: Structure and biological evaluation
Tarushi, A., Polatoglou, E., Kljun, J., Turel, I., Psomas, G., & Kessissoglou, D. P. (2011) · Dalton Transactions · doi:10.1039/c1dt10870k · Cited by 161
Anjomshoa, M., Fatemi, S. J., Torkzadeh-Mahani, M., & Hadadzadeh, H. (2014) · Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2014.02.048 · Cited by 161
Metal Ion-dependent Effects of Clioquinol on the Fibril Growth of an Amyloid β Peptide
Raman, B., Ban, T., Yamaguchi, K.-I., Sakai, M., Kawai, T., Naiki, H., & Goto, Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500309200 · Cited by 159
Copper deficiency and neurological disorders in man and animals
Zatta, P. F., & Frank, A. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.10.001 · Cited by 170
Self-citationGontijo, V. S., Viegas, F. P. D., Ortiz, C. J. C., Silva, M. D. F., Damásio, C. M., Rosa, M. C., Campos, T. G., Couto, D. S., Dias, K. S. T., & Viegas, C. (2019) · Current Neuropharmacology · doi:10.2174/1385272823666191021124443 · Cited by 160
Zinc complexes of the antibacterial drug oxolinic acid: Structure and DNA-binding properties
Tarushi, A., Psomas, G., Raptopoulou, C. P., & Kessissoglou, D. P. (2009) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2009.03.007 · Cited by 145
Zhai, S., Yang, L., Cui, Q. C., Sun, Y., Dou, Q. P., & Yan, B. (2009) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-009-0594-5 · Cited by 137
Tarushi, A., Raptopoulou, C. P., Psycharis, V., Terzis, A., Psomas, G., & Kessissoglou, D. P. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.02.021 · Cited by 133
Biometals and Their Therapeutic Implications in Alzheimer's Disease
Ayton, S., Lei, P., & Bush, A. I. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0312-z · Cited by 141
Preparation and Study of New Poly‐8‐Hydroxyquinoline Chelators for an anti‐Alzheimer Strategy
Deraeve, C., Boldron, C., Maraval, A., Mazarguil, H., Gornitzka, H., Vendier, L., Pitié, M., & Meunier, B. (2008) · Chemistry – A European Journal · doi:10.1002/chem.200701024 · Cited by 127
Aluminum-triggered structural modifications and aggregation of β-amyloids
Ricchelli, F., Drago, D., Filippi, B., Tognon, G., & Zatta, P. F. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5141-0 · Cited by 140
Self-citationTabassum, S., Asim, A., Arjmand, F., Afzal, M. F., & Bagchi, V. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.09.051 · Cited by 125
Tarushi, A., Lafazanis, K., Kljun, J., Turel, I., Pantazaki, Α. A., Psomas, G., & Kessissoglou, D. P. (2012) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2012.12.009 · Cited by 123
Deka, B., Sarkar, T., Banerjee, S., Kumar, A., Mukherjee, S., Deka, S., Saikia, K. K., & Hussain, A. (2016) · Dalton Transactions · doi:10.1039/c6dt03660k · Cited by 121
Tarushi, A., Karaflou, Z., Kljun, J., Turel, I., Psomas, G., Papadopoulos, A. N., & Kessissoglou, D. P. (2013) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2013.07.013 · Cited by 116
Tarushi, A., Totta, X., Papadopoulos, A. N., Kljun, J., Turel, I., Kessissoglou, D. P., & Psomas, G. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.12.019 · Cited by 115
Cooper, G. J. S. (2011) · Drugs · doi:10.2165/11591370-000000000-00000 · Cited by 122
Werner coordination chemistry and neurodegeneration
Telpoukhovskaia, M. A., & Orvig, C. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35236b · Cited by 112
Copper and Alzheimer’s Disease
Mathys, Z. K., & White, A. R. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-60189-2_10 · Cited by 125
Barilli, A., Atzeri, C., Bassanetti, I., Ingoglia, F., Dall’Asta, V., Bussolati, O., Maffini, M., Mucchino, C., & Marchiò, L. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400592n · Cited by 124
Mandegani, Z., Asadi, Z., Asadi, M., Karbalaei‐Heidari, H. R., & Rastegari, B. (2016) · Dalton Transactions · doi:10.1039/c5dt04788a · Cited by 104
Liu, Y., Wei, J.-H., Chen, Z., Liu, M., Gu, Y., Huang, K.-B., Li, Z.-Q., & Liang, H. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.08.033 · Cited by 103
Small molecule inhibitors of Aβ‐aggregation and neurotoxicity
Hawkes, C. A., Ng, V., & McLaurin, J. (2009) · Drug Development Research · doi:10.1002/ddr.20290 · Cited by 119
Effects of Clioquinol on Metal-Triggered Amyloid-β Aggregation Revisited
Mancino, A. M., Hindo, S. S., Kochi, A., & Lim, M. H. (2009) · Inorganic Chemistry · doi:10.1021/ic9014256 · Cited by 102
The significance of copper chelators in clinical and experimental application
Ding, X., Xie, H., & Kang, Y. J. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.06.010 · Cited by 116
Esmieu, C., Guettas, D., Conte‐Daban, A., Sabater, L., Faller, P., & Hureau, C. (2019) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.9b00995 · Cited by 110
Gobec, M., Kljun, J., Sosič, I., Mlinarič‐Raščan, I., Uršič, M., Gobec, S., & Turel, I. (2014) · Dalton Transactions · doi:10.1039/c4dt00463a · Cited by 100
Chelation therapy for neurodegenerative diseases
Bolognin, S., Drago, D., Messori, L., & Zatta, P. (2009) · Medicinal Research Reviews · doi:10.1002/med.20148 · Cited by 97
Self-citationGomes, L. M., Vieira, R. P., Jones, M. R., Wang, M. C. P., Dyrager, C., de Souza-Fagundes, E. M., Silva, J. G. D., Storr, T., & Beraldo, H. D. O. (2014) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2014.04.011 · Cited by 101
Prati, F., Bergamini, C., Fato, R., Soukup, O., Korabecny, J., Andrisano, V., Bartolini, M., & Bolognesi, M. L. (2016) · ChemMedChem · doi:10.1002/cmdc.201600014 · Cited by 90
Domingo, J. L. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-102-315 · Cited by 91
Garrison, A. T., Abouelhassan, Y., Norwood, V. M., Kallifidas, D., Bai, F., Nguyen, M. T., Rolfe, M. A., Burch, G. M., Jin, S., Luesch, H., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b02004 · Cited by 92
Tarushi, A., Kljun, J., Turel, I., Pantazaki, Α. A., Psomas, G., & Kessissoglou, D. P. (2012) · New Journal of Chemistry · doi:10.1039/c2nj40798a · Cited by 83
Hölscher, C. (2005) · Reviews in the Neurosciences · doi:10.1515/revneuro.2005.16.3.181 · Cited by 82
Ferrada, E., Arancibia, V., Loeb, B., Norambuena, E., Olea-Azar, C., & Huidobro-Toro, J. P. (2007) · NeuroToxicology · doi:10.1016/j.neuro.2007.02.004 · Cited by 81
Kokulnathan, T., & Chen, S.-M. (2019) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.8b05650 · Cited by 81
Kokulnathan, T., Priya, T. S., & Wang, T. (2019) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.9b02891 · Cited by 80
Thamilarasan, V., Jayamani, A., & Sengottuvelan, N. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.09.073 · Cited by 79
Finkelstein, D. I., Hare, D. J., Billings, J. L., Sedjahtera, A., Nurjono, M., Arthofer, E., George, S., Culvenor, J. G., Bush, A. I., & Adlard, P. A. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00253 · Cited by 87
Serda, M., Kalinowski, D. S., Rasko, N. B., Potůčková, E., Mrozek‐Wilczkiewicz, A., Musioł, R., Małecki, J. G., Sajewicz, M., Ratuszna, A., Muchowicz, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110291 · Cited by 76
Radioiodinated clioquinol as a biomarker for β‐amyloid: Zn2+ complexes in Alzheimer's disease
Opazo, C., Luza, S., Villemagne, V. L., Volitakis, I., Rowe, C., Barnham, K. J., Strozyk, D., Masters, C. L., Cherny, R. A., & Bush, A. I. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00196.x · Cited by 76
Structure and DNA-binding properties of bis(quinolonato)bis(pyridine)zinc(II) complexes
Tarushi, A., Psomas, G., Raptopoulou, C. P., Psycharis, V., & Kessissoglou, D. P. (2009) · Polyhedron · doi:10.1016/j.poly.2009.04.003 · Cited by 72
Halevas, E. G., Mavroidi, B., Pelecanou, M., & Hatzidimitriou, A. G. (2021) · Inorganica Chimica Acta · doi:10.1016/j.ica.2021.120407 · Cited by 70
8-Hydroxyquinolines Are Boosting Agents of Copper-Related Toxicity in Mycobacterium tuberculosis
Shah, S., Dalecki, A. G., Malalasekera, A. P., Crawford, C. L., Michalek, S. M., Kutsch, O., Sun, J., Bossmann, S. H., & Wolschendorf, F. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00325-16 · Cited by 75
Hybrid Multifunctional Modulators Inhibit Multifaceted Aβ Toxicity and Prevent Mitochondrial Damage
Rajasekhar, K., Mehta, K., & Govindaraju, T. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00033 · Cited by 69
Hydroxyquinoline based binders: Promising ligands for chelatotherapy?
Budimir, A., Humbert, N., Elhabiri, M., Nierengarten, I., Biruš, M., & Albrecht‐Gary, A. (2010) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2010.08.014 · Cited by 72
Redox-Active Metal Ions and Amyloid-Degrading Enzymes in Alzheimer’s Disease
Kim, N., & Lee, H. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147697 · Cited by 73
Puentes-Díaz, N., Chaparro, D., Morales-Morales, D., Flores-Gaspar, A., & Alí-Torres, J. (2023) · ACS Omega · doi:10.1021/acsomega.2c06939 · Cited by 67
Sharma, A., Pachauri, V., & Flora, S. J. S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01247 · Cited by 67
Sumithaa, C., & Ganeshpandian, M. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c01027 · Cited by 69
Metal Ion Signaling in Biomedicine
Rodriguez, R., Müller, S., Colombeau, L., Solier, S., Sindikubwabo, F., & Cañeque, T. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00577 · Cited by 76
Tarushi, A., Totta, X., Raptopoulou, C. P., Psycharis, V., Psomas, G., & Kessissoglou, D. P. (2012) · Dalton Transactions · doi:10.1039/c2dt30547j · Cited by 66
Chen, D., & Dou, Q. P. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.6.739 · Cited by 71
Nguyen, M., Robert, A., Sournia‐Saquet, A., Vendier, L., & Meunier, B. (2014) · Chemistry – A European Journal · doi:10.1002/chem.201402143 · Cited by 65
Rowińska‐Żyrek, M., Salerno, M., & Kozłowski, H. (2014) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2014.03.026 · Cited by 73
Oliveri, V., Lanza, V., Milardi, D., Viale, M., Maric, I., Sgarlata, C., & Vecchio, G. (2017) · Metallomics · doi:10.1039/c7mt00156h · Cited by 64
Repurposing old drugs as new inhibitors of the ubiquitin-proteasome pathway for cancer treatment
Yang, H., Chen, X., Li, K., Cheaito, H. A., Yang, Q., Wu, G., Liu, J., & Dou, Q. P. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.12.013 · Cited by 65
Tarushi, A., Kakoulidou, C., Raptopoulou, C. P., Psycharis, V., Kessissoglou, D. P., Zoi, I., Papadopoulos, A. N., & Psomas, G. (2017) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2017.02.010 · Cited by 62
Kenche, V. B., Zawisza, I., Masters, C. L., Bal, W., Barnham, K. J., & Drew, S. C. (2013) · Inorganic Chemistry · doi:10.1021/ic302289r · Cited by 59
Karthik, R., Kumar, J. V., Chen, S., Seerangan, K., Karuppiah, C., Chen, T.-W., & Muthuraj, V. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b06851 · Cited by 59
Novel drug targets based on metallobiology of Alzheimer's disease
Bandyopadhyay, S., Huang, X., Lahiri, D. K., & Rogers, J. T. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.525352 · Cited by 63
Gogoi, A., Das, A., Frontera, A., Verma, A. K., & Bhattacharyya, M. K. (2019) · Inorganica Chimica Acta · doi:10.1016/j.ica.2019.04.047 · Cited by 58
Zhao, J., & Fan, Z. (2019) · Microchimica Acta · doi:10.1007/s00604-019-4020-6 · Cited by 56
Pharmacotherapeutic targets in Alzheimer's disease
Biran, Y., Masters, C. L., Barnham, K. J., Bush, A. I., & Adlard, P. A. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00595.x · Cited by 57
Wang, Q., Mosser, D. D., & Bag, J. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi395 · Cited by 61
Potočňák, I., Vranec, P., Kuchárová, V., Sabolová, D., Vataščinová, M., Kudláčová, J., Radojević, I. D., Čomić, L. R., Marković, B. S., Volarević, V., et al. (2015) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2015.10.015 · Cited by 54
Qin, Q., Wei, Z., Wang, Z., Huang, X., Tan, M., Zou, H., & Liang, H. (2020) · Chemical Communications · doi:10.1039/d0cc00524j · Cited by 54
Ji, H., & Zhang, H. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.10.047 · Cited by 58
Moret, V., Laras, Y., Cresteil, T., Aubert, G., Ping, D. Q., Chen, D., Barthélémy-Requin, M., Béclin, C., Peyrot, V., Allegro, D., et al. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.03.042 · Cited by 54
New Cyclodextrin‐Bearing 8‐Hydroxyquinoline Ligands as Multifunctional Molecules
Oliveri, V., Puglisi, A., Viale, M., Aiello, C., Sgarlata, C., Vecchio, G., Clarke, J., Milton, J., & Spencer, J. (2013) · Chemistry - A European Journal · doi:10.1002/chem.201300237 · Cited by 53
Bis-8-hydroxyquinoline ligands as potential anti-Alzheimer agents
Deraeve, C., Piti?, M., Mazarguil, H., & Meunier, B. (2007) · New Journal of Chemistry · doi:10.1039/b616085a · Cited by 53
Zinc complexes of salicylaldehydes: Synthesis, characterization and DNA-binding properties
Zianna, A., Psomas, G., Hatzidimitriou, A. G., Coutouli‐Argyropoulou, E., & Lalia‐Kantouri, M. (2013) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2013.07.031 · Cited by 52
Metal Complexes or Chelators with ROS Regulation Capacity: Promising Candidates for Cancer Treatment
Li, X., Wang, Y., Li, M., Wang, H., & Dong, X. (2021) · Molecules · doi:10.3390/molecules27010148 · Cited by 57
Nguyen, M., Vendier, L., Stigliani, J., Meunier, B., & Robert, A. (2016) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.201601120 · Cited by 54
Preparation of Tetradentate Copper Chelators as Potential Anti‐Alzheimer Agents
Zhang, W., Huang, D., Huang, M., Huang, J., Wang, D., Liu, X., Nguyen, M., Vendier, L., Mazères, S., Robert, A., et al. (2018) · ChemMedChem · doi:10.1002/cmdc.201700734 · Cited by 52
Dual effects of curcumin on neuronal oxidative stress in the presence of Cu(II)
Huang, H., Lin, C., Liu, W., Jiang, R.-R., & Jiang, Z.-F. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.04.004 · Cited by 52
Metadata
- Authors
- Di Vaira, M., Bazzicalupi, C., Orioli, P., Messori, L., Bruni, B., & Zatta, P.
- Affiliations
- Department of Chemistry, University of Florence, via della Lastruccia 3, Sesto Fiorentino, Firenze, Italy, and CNR-Institute for Biomedical Technologies, Padova Unit “Metalloproteins”, University of Padova, Padova, Italy
- University of Padua (IT)
- ORCID
- Bazzicalupi, Carla
- Venue
- Inorganic Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2004-05-29
- Volume
- 43
- Issue
- 13
- Pages
- 3795-3797
- ISSN
- 0020-1669 (ISSN-L)
- 1520-510X
- OpenAlex
- W1964081428
- Cited by
- 292
- References
- 16
- Citations by year
- 2026: 1 · 2025: 12 · 2024: 10 · 2023: 11 · 2022: 12 · 2021: 17 · 2020: 21 · 2019: 20 · 2018: 6 · 2017: 18 · 2016: 13 · 2015: 14 · 2014: 25 · 2013: 17 · 2012: 19
- FWCI
- 6.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Inorganic Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Florence Research (University of Florence) (submittedVersion)
- Funders
- Korea Institute of Energy Research
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Metal complexes synthesis and properties
- Physical Sciences › Chemistry › Inorganic Chemistry › Crystal structures of chemical compounds
- Keywords
- clioquinol, Alzheimer's disease, 8-hydroxyquinoline, zinc(II) complexes, copper(II) complexes, metal complexation, coordination polyhedra, metal metabolism, protein aggregation
- MeSH terms
- Alzheimer Disease, Brain, Chelating Agents, Copper, Clioquinol, Molecular Conformation, Organometallic Compounds, Zinc, Crystallography, X-Ray
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.